Ashish Maheshwari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ashish Maheshwari, Director of Balaxi Overseas Private Limited (promoter entity), has submitted a declaration to the National Stock Exchange on behalf of the promoters and promoter group of Balaxi Pharmaceuticals Limited. The declaration confirms that the promoters and persons acting in concert have NOT created any share encumbrance (pledge) during the financial year ended March 31, 2026. This is a regulatory compliance filing required under SEBI regulations, specifically meant for disclosure by promoters regarding their pledge activities on company shares.
This is a positive signal for shareholders as it indicates promoters have not encumbered their shareholding, meaning their stakes are not pledged against loans. This reduces risk for investors as promoter shares would not be at risk of forced sale in case of loan defaults.